Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market
Holding PYXS?
Track your performance easily

Pyxis Oncology (PYXS) Financial Statements

354 Followers

Pyxis Oncology Financial Overview

Pyxis Oncology's market cap is currently ―. The company's EPS TTM is $-1.255; its P/E ratio is -2.88; Pyxis Oncology is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 16.15M$ 562.00K$ 600.00K$ 600.00K
Gross Profit-$ 15.67M$ 562.00K$ 600.00K$ 600.00K
EBIT$ -17.30M$ -5.61M$ -17.77M$ -23.07M$ -16.65M
EBITDA$ -15.43M$ -4.49M$ -17.08M$ -24.02M$ -17.38M
Net Income Common Stockholders$ -17.30M$ -3.26M$ -15.60M$ -23.07M$ -15.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 155.72M$ 157.03M$ 119.30M$ 132.97M$ 144.13M
Total Assets$ 208.39M$ 220.22M$ 173.73M$ 186.69M$ 175.23M
Total Debt$ 19.53M$ 20.78M$ 21.33M$ 21.62M$ 21.26M
Net Debt$ -136.19M$ -136.25M$ -97.97M$ -111.35M$ -122.88M
Total Liabilities$ 38.59M$ 36.06M$ 48.02M$ 48.75M$ 29.95M
Stockholders Equity$ 169.79M$ 184.14M$ 125.70M$ 137.95M$ 145.28M
Cash Flow-
Free Cash Flow$ -3.01M$ -20.95M$ -15.25M$ -17.64M$ -13.29M
Operating Cash Flow$ -3.01M$ -20.71M$ -15.25M$ -17.58M$ -11.03M
Investing Cash Flow$ 4.00K$ -18.50M$ 10.23M$ 6.57M$ -22.25M
Financing Cash Flow$ 110.00K$ 57.51M$ -25.00K$ -171.00K$ 6.13M
Currency in USD

Pyxis Oncology Earnings and Revenue History

Pyxis Oncology Debt to Assets

Pyxis Oncology Cash Flow

Pyxis Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis